{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T00:18:18Z","timestamp":1760487498291,"version":"build-2065373602"},"reference-count":54,"publisher":"Journal of Biological Methods","issue":"5","license":[{"start":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T00:00:00Z","timestamp":1674864000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["HPR"],"abstract":"<jats:p>Purpose of Review\nSeizures are a hyperexcitable, and hypersynchronous imbalance between excitatory and inhibitory factors (E\/I imbalance) in neurotransmission, and epilepsy is the recurrent manifestation of seizures within a reasonable time frame and without being attributable to a reversible cause. Brivaracetam is a derivative of the antiepileptic agent, levetiracetam, that is used as adjuvant therapy for focal onset seizures. It was approved by the FDA in 2016 and has shown promising results with minimal adverse effect reactions in clinical trials.\nRecent Findings\nBrivaracetam has been used in multiple clinical trials at various dosages in adults that have partial-onset seizures refractory to conventional treatment. A meta-analysis in 2016 showed that brivaracetam as adjunctive therapy was statically significant in its reduction of adults with drug-refractory seizure frequency.1&amp;nbsp;The most commonly reported adverse effects that patients who were taking brivaracetam experienced were somnolence, headache, and dizziness. Further studies are necessary to conclude long term efficacy and safety profile of brivaracetam.\nConclusion\nThe treatment of epilepsy with pharmacologic agents is a difficult task due to balancing the efficacy of the drug with the side effect profile that will allow for the best quality of life for the patient. There are approximately 30 antiepileptic agents for clinicians to choose from. Brivaracetam is a novel antiepileptic agent that was approved for use by the FDA in 2016 and is showing promising results as monotherapy and adjunctive therapy in individuals with drug-refractory focal seizures while minimizing adverse drug reactions.<\/jats:p>","DOI":"10.52965\/001c.56782","type":"journal-article","created":{"date-parts":[[2023,1,28]],"date-time":"2023-01-28T13:14:35Z","timestamp":1674911675000},"page":"1","source":"Crossref","is-referenced-by-count":4,"title":["Brivaracetam to Treat Partial Onset Seizures in Adults\u00a0"],"prefix":"10.14440","volume":"10","author":[{"given":"Dustin","family":"Latimer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evan","family":"Falgoust","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Ingraffia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alaa","family":"Abd-Elsayed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elyse","family":"M. Cornett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rupin","family":"Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JooHee","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"M. Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan","family":"D. Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latha","family":"Ganti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"5574","published-online":{"date-parts":[[2023,1,28]]},"reference":[{"issue":"6","key":"ref1","doi-asserted-by":"publisher","first-page":"a022426","DOI":"10.1101\/cshperspect.a022426","article-title":"Seizures and Epilepsy: An Overview for Neuroscientists","volume":"5","author":"C. E. Stafstrom","year":"2015","journal-title":"Cold Spring Harbor Perspectives in Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/2157-1422","issn-type":"print"},{"issue":"1","key":"ref2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.emc.2010.08.001","article-title":"Pathophysiology and Definitions of Seizures and Status Epilepticus","volume":"29","author":"J. Stephen Huff","year":"2011","journal-title":"Emergency Medicine Clinics of North America","ISSN":"https:\/\/id.crossref.org\/issn\/0733-8627","issn-type":"print"},{"issue":"1","key":"ref3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0022-3565(25)20996-X","article-title":"Chronic ethanol administration alters \u03b3-aminobutyric acid, pentobarbital and ethanol-mediated 36Cl- uptake in cerebral cortical synaptoneurosomes","volume":"246","author":"A.L. Morrow","year":"1988","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"ref4","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1111\/j.1528-1157.1987.tb03652.x","article-title":"Effectiveness of Multiple EEGs in Supporting the Diagnosis of Epilepsy: An Operational Curve","volume":"28","author":"Martin Salinsky","year":"1987","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"issue":"21","key":"ref5","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1212\/01.wnl.0000285084.93652.43","article-title":"Practice parameter: Evaluating an apparent unprovoked first seizure in adults (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society","volume":"69","author":"A. Krumholz","year":"2007","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"issue":"88","key":"ref6","article-title":"Advanced neuroimaging techniques for evaluating pediatric epilepsy","volume":"63","author":"Y. Lee","year":"2020","journal-title":"Clin Exp Pediatr"},{"issue":"6","key":"ref7","doi-asserted-by":"crossref","DOI":"10.1111\/epi.15612","article-title":"Recommendations for the use of structural magnetic resonance imaging in the care of patients with epilepsy: A consensus report from the International League Against Epilepsy Neuroimaging Task Force","volume":"60","author":"A. Bernasconi","year":"2019","journal-title":"Epilepsia"},{"key":"ref8","first-page":"128","article-title":"Functionality of triggers for epilepsy patients assessed by text and data mining of medical and nursing records","volume":"225","author":"E. Kivek\u00e4s","year":"2016","journal-title":"Stud Health Technol Inform"},{"issue":"9","key":"ref9","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/j.1528-1167.2005.31405.x","article-title":"Photic- and pattern-induced seizures: A review for the epilepsy foundation of America working group","volume":"46","author":"Robert S. Fisher","year":"2005","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"issue":"10","key":"ref10","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1111\/epi.13121","article-title":"A definition and classification of status epilepticus - Report of the ILAE Task Force on Classification of Status Epilepticus","volume":"56","author":"Eugen Trinka","year":"2015","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.0000000000002545","article-title":"Brivaracetam add-on for refractory focal epilepsy","volume":"86","author":"S. Lattanzi","journal-title":"Neurology"},{"issue":"2","key":"ref12","first-page":"118","article-title":"Effects of age and underlying brain dysfunction on the postictal state","volume":"19","author":"W.H. Theodore","year":"2011"},{"issue":"1","key":"ref13","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/dmcn.14015","article-title":"First-ever convulsive seizures in children presenting to the emergency department: risk factors for seizure recurrence and diagnosis of epilepsy","volume":"61","author":"Stefano Sartori","year":"2019","journal-title":"Developmental Medicine &amp; Child Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0012-1622","issn-type":"print"},{"issue":"2","key":"ref14","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1684\/epd.2017.0916","article-title":"Epilepsy after cerebral infection: a review of the literature and the potential for surgery","volume":"19","author":"Georgia Ramantani","year":"2017","journal-title":"Epileptic Disord","ISSN":"https:\/\/id.crossref.org\/issn\/1294-9361","issn-type":"print"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.seizure.2015.10.002","article-title":"Traumatic brain injury and epilepsy: Underlying mechanisms leading to seizure","volume":"33","author":"Brandon P. Lucke-Wold","year":"2015","journal-title":"Seizure","ISSN":"https:\/\/id.crossref.org\/issn\/1059-1311","issn-type":"print"},{"issue":"8","key":"ref16","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1111\/epi.13448","article-title":"Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors","volume":"57","author":"Edoardo Ferlazzo","year":"2016","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"article-title":"Contributions of electroencephalography and electrocorticography to the neurosurgical treatment of the epilepsies","year":"1975","author":"P. Gloor","key":"ref17"},{"issue":"7","key":"ref18","doi-asserted-by":"publisher","first-page":"a022368","DOI":"10.1101\/cshperspect.a022368","article-title":"Initiation, propagation, and termination of partial (focal) seizures","volume":"5","author":"Marco de Curtis","year":"2015","journal-title":"Cold Spring Harbor Perspectives in Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/2157-1422","issn-type":"print"},{"key":"ref19","article-title":"Reevaluating the mechanisms of focal ictogenesis: The role of low-voltage fast activity","author":"M de Curtis","year":"2009","journal-title":"Epilepsia"},{"issue":"3-4","key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/bf00235500","article-title":"Extracellular free calcium and potassium during paroxysmal activity in the cerebral cortex of the cat","volume":"27","author":"U. Heinemann","year":"1977","journal-title":"Experimental Brain Research","ISSN":"https:\/\/id.crossref.org\/issn\/0014-4819","issn-type":"print"},{"issue":"3","key":"ref21","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1152\/jn.00207.2011","article-title":"Changes in action potential features during focal seizure discharges in the entorhinal cortex of the in vitro isolated guinea pig brain","volume":"106","author":"Federica Trombin","year":"2011","journal-title":"Journal of Neurophysiology","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3077","issn-type":"print"},{"issue":"5","key":"ref22","first-page":"1","article-title":"Seizures and epilepsy: An overview for neuroscientists","volume":"7","author":"C.E. Stafstrom","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"4","key":"ref23","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1113\/jphysiol.2012.239590","article-title":"Synchronization and desynchronization in epilepsy: Controversies and hypotheses","volume":"591","author":"Premysl Jiruska","year":"2013","journal-title":"Journal of Physiology","ISSN":"https:\/\/id.crossref.org\/issn\/0022-3751","issn-type":"print"},{"issue":"6","key":"ref24","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1093\/brain\/awg144","article-title":"Epileptic fast intracerebral EEG activity: Evidence for spatial decorrelation at seizure onset","volume":"126","author":"F. Wendling","year":"2003","journal-title":"Brain","ISSN":"https:\/\/id.crossref.org\/issn\/1460-2156","issn-type":"print"},{"issue":"9","key":"ref25","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1111\/j.1528-1167.2006.00622.x","article-title":"How long do most seizures last? A systematic comparison of seizures recorded in the epilepsy monitoring unit","volume":"47","author":"Sigmund Jenssen","year":"2006","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"issue":"15","key":"ref26","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1056\/nejm198410113111503","article-title":"The Prognosis for Seizure Control in Newly Diagnosed Epilepsy","volume":"311","author":"Robert D. C. Elwes","year":"1984","journal-title":"New England Journal of Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/0028-4793","issn-type":"print"},{"key":"ref27","series-title":"Harrison\u2019s Principles of Internal Medicine","first-page":"2498","article-title":"Seizures and epilepsy","author":"D. Lowenstein","year":"2008"},{"issue":"9","key":"ref28","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1111\/ene.12629","article-title":"Surgically implanted and non\u2010invasive vagus nerve stimulation: A review of efficacy, safety and tolerability","volume":"22","author":"E. Ben\u2010Menachem","year":"2015","journal-title":"European Journal of Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/1351-5101","issn-type":"print"},{"issue":"2","key":"ref29","doi-asserted-by":"publisher","first-page":"47","DOI":"10.4103\/2152-7806.91610","article-title":"Vagus nerve stimulation for epilepsy: A review of the peripheral mechanisms","volume":"3","author":"ScottE Krahl","year":"2012","journal-title":"Surgical Neurology International","ISSN":"https:\/\/id.crossref.org\/issn\/2152-7806","issn-type":"print"},{"issue":"1","key":"ref30","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1212\/wnl.51.1.48","article-title":"Vagus nerve stimulation therapy for partial-onset seizures: A randomized active-control trial","volume":"51","author":"A. Handforth","year":"1998","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"key":"ref31","article-title":"A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures","author":"R. George","year":"1995","journal-title":"Neurology"},{"issue":"2","key":"ref32","first-page":"92","article-title":"Brivaracetam (Briviact): A novel adjunctive therapy for partial-onset seizures","volume":"42","author":"F. Khaleghi","year":"2017","journal-title":"P T"},{"article-title":"Seizure, Pseudoseizures","year":"2018","author":"J.S. Huff","key":"ref33"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/j.1528-1167.2010.02869.x","article-title":"Targeting SV2A for discovery of antiepileptic drugs","volume":"51","author":"Rafal M. Kaminski","year":"2010","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.cd005612.pub4","article-title":"Pregabalin add-on for drug-resistant focal epilepsy","author":"Mariangela Panebianco","year":"2019","journal-title":"Cochrane Database of Systematic Reviews","ISSN":"https:\/\/id.crossref.org\/issn\/1465-1858","issn-type":"print"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2147\/cpaa.s114072","article-title":"A review of the pharmacology and clinical efficacy of brivaracetam","volume":"10","author":"Pavel Klein","year":"2018","journal-title":"Clinical Pharmacology: Advances and Applications","ISSN":"https:\/\/id.crossref.org\/issn\/1179-1438","issn-type":"print"},{"key":"ref37","first-page":"5719","article-title":"Brivaracetam: Review of its pharmacology and potential use as adjunctive therapy in patients with partial-onset seizures","volume":"9","author":"L. Mumoli","year":"2015","journal-title":"Drug Des Devel Ther"},{"issue":"1","key":"ref38","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1111\/j.1365-2125.2008.03158.x","article-title":"The pharmacokinetics, CNS pharmacodynamics and adverse event profile of brivaracetam after multiple increasing oral doses in healthy men","volume":"66","author":"Paul Rolan","year":"2008","journal-title":"British Journal of Clinical Pharmacology","ISSN":"https:\/\/id.crossref.org\/issn\/0306-5251","issn-type":"print"},{"issue":"6","key":"ref39","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1212\/wnl.0b013e3181ec7f7f","article-title":"Adjunctive brivaracetam for refractory partial-onset seizures: A randomized, controlled trial","volume":"75","author":"J. A. French","year":"2010","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"issue":"1","key":"ref40","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1528-1167.2012.03598.x","article-title":"Efficacy and tolerability of adjunctive brivaracetam in adults with uncontrolled partial-onset seizures: A phase IIb, randomized, controlled trial","volume":"54","author":"Wim Van Paesschen","year":"2013","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"issue":"1","key":"ref41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/epi.12432","article-title":"Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: Results from a double\u2010blind, randomized, placebo\u2010controlled trial","volume":"55","author":"Philippe Ryvlin","year":"2014","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"issue":"1","key":"ref42","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/epi.12433","article-title":"Brivaracetam as an adjunctive treatment for uncontrolled partial epilepsy in adults: A phase III randomized, double-blind, placebo-controlled trial","volume":"55","author":"Victor Biton","year":"2014","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"issue":"1","key":"ref43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/epi.12391","article-title":"Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: Results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial","volume":"55","author":"Patrick Kwan","year":"2014","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"key":"ref44","first-page":"1","article-title":"Evaluation of the first seizure in adults","author":"S.C. Schachter","year":"2016","journal-title":"UpToDate"},{"issue":"12","key":"ref45","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1111\/epi.13212","article-title":"A randomized, double\u2010blind, placebo\u2010controlled, multicenter, parallel\u2010group study to evaluate the efficacy and safety of adjunctive brivaracetam in adult patients with uncontrolled partial\u2010onset seizures","volume":"56","author":"Pavel Klein","year":"2015","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"},{"issue":"3","key":"ref46","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1212\/wnl.0000000000002864","article-title":"Efficacy and safety of brivaracetam for partial-onset seizures in 3 pooled clinical studies","volume":"87","author":"Elinor Ben-Menachem","year":"2016","journal-title":"Neurology","ISSN":"https:\/\/id.crossref.org\/issn\/0028-3878","issn-type":"print"},{"issue":"2","key":"ref47","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1517\/14656566.2016.1135129","article-title":"Brivaracetam for the treatment of epilepsy","volume":"17","author":"Pavel Klein","year":"2016","journal-title":"Expert Opinion on Pharmacotherapy","ISSN":"https:\/\/id.crossref.org\/issn\/1465-6566","issn-type":"print"},{"key":"ref48","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.yebeh.2017.12.024","article-title":"Efficacy, safety, and tolerability of brivaracetam with concomitant lamotrigine or concomitant topiramate in pooled Phase III randomized, double-blind trials: A post-hoc analysis","volume":"80","author":"Selim Benbadis","year":"2018","journal-title":"Epilepsy &amp; Behavior","ISSN":"https:\/\/id.crossref.org\/issn\/1525-5050","issn-type":"print"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"106218","DOI":"10.1016\/j.eplepsyres.2019.106218","article-title":"Pharmacokinetic interaction of brivaracetam on other antiepileptic drugs in adults with focal seizures: Pooled analysis of data from randomized clinical trials","volume":"158","author":"Brian D. Moseley","year":"2019","journal-title":"Epilepsy Research","ISSN":"https:\/\/id.crossref.org\/issn\/0920-1211","issn-type":"print"},{"author":"K Al Khalili","key":"ref50","article-title":"Idiopathic Generalized Epilepsy"},{"author":"C. Korff","key":"ref51","article-title":"ILAE classification of seizures and epilepsy"},{"issue":"6","key":"ref52","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1111\/j.1553-2712.2001.tb00175.x","article-title":"Emergency department management of patients with seizures: A multicenter study","volume":"8","author":"J. Stephen Huff","year":"2001","journal-title":"Academic Emergency Medicine","ISSN":"https:\/\/id.crossref.org\/issn\/1069-6563","issn-type":"print"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.seizure.2017.03.001","article-title":"Electroencephalography after a single unprovoked seizure","volume":"49","author":"D.B. Debicki","year":"2017","journal-title":"Seizure"},{"issue":"4","key":"ref54","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/epi.12550","article-title":"ILAE Official Report: A practical clinical definition of epilepsy","volume":"55","author":"Robert S. Fisher","year":"2014","journal-title":"Epilepsia","ISSN":"https:\/\/id.crossref.org\/issn\/0013-9580","issn-type":"print"}],"container-title":["Health Psychology Research"],"original-title":[],"link":[{"URL":"https:\/\/api.healthpr.org\/uploads\/file\/asp\/202504071654321d52f6455.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.healthpr.org\/uploads\/file\/asp\/202504071654321d52f6455.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T03:34:47Z","timestamp":1760412887000},"score":1,"resource":{"primary":{"URL":"https:\/\/healthpr.org\/journal\/HPR\/10\/5\/10.52965\/001c.56782"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,28]]},"references-count":54,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2022,10,11]]}},"URL":"https:\/\/doi.org\/10.52965\/001c.56782","relation":{},"ISSN":["2420-8124"],"issn-type":[{"type":"electronic","value":"2420-8124"}],"subject":[],"published":{"date-parts":[[2023,1,28]]}}}